Notably, semaglutide has also been associated with a 70% reduction in heart failure hospitalizations, highlighting its potential benefits beyond weight management
(See Case Study: Electroretinography in Diabetic Retinopathy, also in this issue.) Further, because carotenoids can curb DR development, the optometrist should consider using a macular pigment optical density device
Switching to branded products may enhance patient safety, a point practices can emphasize in patient communications to build trust
Addressing this unmet need head-on is critical, and while there are pharmaceutical treatments for the excessive sleepiness associated with OSA, tirzepatide has the potential to be the first pharmaceutical treatment for the underlying disease. Lilly has received U.S
Increased Risk of Hair Loss With GLP-1 Receptor Agonists: A Real-World Multicenter Cohort Study